Immune checkpoint inhibitors for unresectable hepatocellular carcinoma

To assess the benefits and harms of immune checkpoint inhibitors versus placebo, no treatment, or other systemic or locoregional therapies for people with unresectable hepatocellular carcinoma.

This is a protocol.

Share/Save
Health topics: